Case Report: Hepatic sarcoidosis-like reaction from neoadjuvant pembrolizumab in early-stage triple-negative breast cancer

Case Report: Hepatic sarcoidosis-like reaction from neoadjuvant pembrolizumab in early-stage triple-negative breast cancer

Drug-induced sarcoidosis-like reaction (DISR) is a rare adverse event associated with immunotherapy. Currently, there is no standardized treatment protocol for DISR linked to immune checkpoint inhibitors (ICIs). This study presents a case of an early-stage triple-negative breast cancer (TNBC) patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Yujing Tan, Yu Wang, Xiaoyan Liu, Qin Ma, Cheng Zeng, Aihua Zhu, Xiaoying Sun, Fei Ma, Jiani Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
triple-negative breast cancer
pembrolizumab
sarcoidosis-like reaction
neoadjuvant immunotherapy
early breast cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589191/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items